Silver Book Fact

Fact image

Annual Total Burden to the U.S. Economy of AMD, Cararact, Diabetic Retinopathy, Glaucoma, Refractive Errors, Visual Impairment and Blindness

Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Expenditures for glaucoma medications are on the rise–mean annual glaucoma medication expenditures per indiviual increased from $445 in 2001 to $557 in 2006.  
  • Close to 50% of participants in the NEI-sponsored Los Angeles Latino Eye Study (LALES) who had diabetes, also had diabetic retinopathy.  
  • The average cost in 2004 per glaucoma patient age 40 to 64 using inpatient services was $2,270. The average cost per patient 65 years and older was $4,929.  
  • Approximately 120,000 people have gone blind because of glaucoma– 9-12% of all cases of blindness in the U.S.  
  • The average annual salary for adults who are visually impaired is close to $10,000 less than for those with normal vision.